Your session is about to expire
← Back to Search
Enhanced PTSD Communication Strategies for Post-Traumatic Stress Disorder (AWARE Trial)
AWARE Trial Summary
This trial studies whether existing PTSD treatments can be improved by adding a writing task and guided responses to enhance patient-therapist communication. 4 participants will get the new approach, and 50 more will be randomly assigned to get the new or usual treatments.
AWARE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAWARE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AWARE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any opportunities for enrolment in this scientific experiment?
"According to clinicaltrials.gov, this medical trial is no longer recruiting patients, having last been updated on October 12th of 2023. Despite the conclusion of patient recruitment for this particular study, 331 other trails are currently seeking participants."
What is the goal of this medical experiment?
"This clinical trial's primary outcome, to be monitored shortly after the conclusion of treatment, is PTSD: CAPS-5 (Posttreatment). Secondary outcomes measure the severity of posttraumatic stress disorder and depression with tests such as the PCL-5 - Self Report and PHQ-9."
Share this study with friends
Copy Link
Messenger